Company Filing History:
3 out of 639 
1 out of 99 
1 out of 1 Years Active: 2014-2016
Title: Yi-Jia Li: Innovator in Cancer Treatment
Introduction
Yi-Jia Li is a prominent inventor based in Duarte, California. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 3 patents, his work focuses on developing methods to inhibit SUMOylation enzymes, which play a crucial role in various cellular processes.
Latest Patents
One of Yi-Jia Li's latest patents is titled "Singleton inhibitors of sumoylation enzymes and methods for their use." This patent describes a SUMOylation inhibitor compound that comprises a singleton scaffold. The method involves administering this compound to inhibit SUMOylation enzymes in cells, particularly in cancer cells, both in vitro and in vivo. Another significant patent is "Inhibition of small ubiquitin-like modifier enzymes with substituted pyrrolo[2,3-b]quinoxalines." This invention outlines methods for inhibiting small ubiquitin-like modifier enzymes using specific compounds, which can also be applied in treating cancer and other diseases.
Career Highlights
Throughout his career, Yi-Jia Li has worked with esteemed organizations such as City of Hope and Sanford-Burnham Medical Research Institute. His research has focused on developing therapeutic strategies that target cancer and degenerative diseases, showcasing his commitment to advancing medical science.
Collaborations
Yi-Jia Li has collaborated with notable colleagues, including Yuan Chen and Daniela Divlianska. These partnerships have contributed to the success of his research and the development of innovative treatments.
Conclusion
Yi-Jia Li's contributions to cancer treatment through his patented inventions highlight his role as a leading innovator in the field. His work continues to pave the way for new therapeutic approaches that may significantly impact patient care.